Veerhealth Care (BOM:511523) Cyclically Adjusted PS Ratio: (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:511523 Veerhealth Care Ltd BOM:511523
66 GF Score
Price ₹48.77
GF Value ₹41.96
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Veerhealth Care Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Veerhealth Care  (BOM:511523) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Veerhealth Care Cyclically Adjusted PS Ratio Related Terms


Veerhealth Care Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Veerhealth Care's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veerhealth Care Cyclically Adjusted PS Ratio Chart

Veerhealth Care Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.15 1.81 3.50 1.80 2.37

Veerhealth Care Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.61 2.46 2.54 2.37 0.00

BOM:511523 vs ZTS: Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Veerhealth Care's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veerhealth Care Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Veerhealth Care's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Veerhealth Care's Cyclically Adjusted PS Ratio falls into.


BOM:511523
66GF Score
Veerhealth Care Ltd BOM:511523
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veerhealth Care Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Veerhealth Care's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Veerhealth Care's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=11.583/167.3573*167.3573
=11.583

Current CPI (Jun. 2026) = 167.3573.

Veerhealth Care Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.199 105.961 0.314
201612 0.649 105.196 1.033
201703 0.309 105.196 0.492
201706 0.493 107.109 0.770
201709 0.935 109.021 1.435
201712 1.091 109.404 1.669
201803 1.197 109.786 1.825
201806 0.781 111.317 1.174
201809 0.648 115.142 0.942
201812 1.210 115.142 1.759
201903 1.639 118.202 2.321
201906 1.487 120.880 2.059
201909 2.796 123.175 3.799
201912 1.584 126.235 2.100
202003 2.481 124.705 3.330
202006 1.258 127.000 1.658
202009 2.322 130.118 2.987
202012 2.827 130.889 3.615
202103 1.278 131.771 1.623
202106 1.752 134.084 2.187
202109 1.628 135.847 2.006
202112 1.931 138.161 2.339
202203 1.434 138.822 1.729
202206 1.851 142.347 2.176
202209 2.833 144.661 3.277
202212 1.986 145.763 2.280
202303 1.844 146.865 2.101
202306 1.791 150.280 1.995
202309 1.853 151.492 2.047
202312 1.348 152.924 1.475
202403 1.575 153.035 1.722
202406 1.020 155.789 1.096
202409 2.584 157.882 2.739
202412 2.178 158.323 2.302
202503 2.830 157.552 3.006
202506 2.237 159.755 2.343
202509 2.052 162.289 2.116
202512 3.586 163.281 3.676
202603 8.530 164.272 8.690
202606 11.583 167.357 11.583

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Veerhealth Care (BOM:511523) Overvalued in 2026?

Based on GuruFocus' analysis, Veerhealth Care stock appears to be overvalued. The current stock price of ₹48.77 is trading 16.2% above its estimated GF Value™ of ₹41.96. GuruFocus considers Veerhealth Care to be Modestly Overvalued.

Key valuation signals for BOM:511523:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: ₹41.96 vs. price of ₹48.77 (16.2% above fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the BOM:511523 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Veerhealth Care Business Description

Address J.S.S. Marg, Near Kalbadevi Post Office, 629-A, 1st Floor, Gazdar House, Mumbai, MH, IND, 400 002
Veerhealth Care Ltd is an India-based pharmaceutical company. It is engaged in the business of trading and manufacturing and marketing research-based Ayurvedic medicines. It operates in a single segment namely Ayurved Pharma Products.
66GF Score

Get the complete analysis for BOM:511523

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹48.77
Price
₹41.96
GF Value